5443092026-01-012026-03-315443092026-03-315443092025-03-315443092025-04-012026-03-315443092026-01-012026-03-31in-capmkt:OtherExpenses1Member5443092025-04-012026-03-31in-capmkt:OtherExpenses1Member5443092026-03-31OtherNoncurrentFinancialAssetsDomain15443092026-03-31OtherNoncurrentAssetsDomain15443092026-03-31OtherCurrentFinancialAssetsDomain15443092026-03-31OtherCurrentAssetsDomain15443092026-03-31OtherCurrentAssetsDomain25443092026-03-31OtherNoncurrentFinancialLiabilitiesDomain15443092026-03-31OtherCurrentFinancialLiabilitiesDomain15443092026-03-31OtherCurrentLiabilitiesDomain15443092026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443092026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443092025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443092025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443092026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544309IKSNOTLISTEDINE115Q01022INVENTURUS KNOWLEDGE SOLUTIONS LIMITEDMain BoardEquity2025-04-012026-03-312026-05-132026-05-05INRMillionsQuarterlyFourth quarterSingle segmentCARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS2026-05-1317:15:002026-05-1318:39:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31UnauditedConsolidated8576520000487300008625250000001391000041836300001267700003405700001376740000604162000025836300000258363000029588000017399000046987000002113760000000-5408000020596800005022900002561970000170710000112.3112.060012.3112.06Notes to the Statement of Audited Consolidated and Standalone Financial Results for the year ended March 31, 2026: <BR> <BR> 1. The above standalone financial results of Inventurus Knowledge Solutions Limited ("the Company") and consolidated financial results of the Company and its subsidiaries (collectively "the Group") and its interest in associate for the quarterand year ended March 31, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on May 13, 2026. The above results for the year ended March 31, 2026 have been audited by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. <BR> <BR> 2. The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards("Ind AS") as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder. <BR> <BR> 3. The figures of the quarter ended March 31, 2026 and March 31, 2025 are balancing figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial years. <BR> <BR> 4. In the consolidated financial results, the net foreign exchange gain aggregating to Rs. 627.47 million for the year ended March 31, 2026 (year ended March 31, 2025 Rs. 37.97 million) and Rs. 352.07 million for the quarter ended March 31, 2026 (quarter ended March 31, 2025 : Rs. (23.67) million) has been netted off against Other expenses. <BR> In the standalone financial results, the net foreign exchange gain aggregating to Rs. 447.32 million for the year ended March 31, 2026 (year ended March 31, 2025 Rs.19.68 million) and Rs. 250.36 million for the quarter ended March 31, 2026 (quarter ended March 31, 2025 : Rs. (19.40) million) has been netted off against Other expenses. <BR> These are exchange differences recognised in accordance with Ind AS 21 - The Effects of Changes in Foreign Exchange Rates. The net foreign exchange gain primarily relates to exchange differences arising on realisation and restatement of foreign currency denominated trade receivables and cash and bank balances. The Company follows a consistent net presentation of foreign exchange differences, irrespective of whether the impact results in a gain or a loss. <BR> <BR> 5. The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers. This in the context of Indian Accounting Standard (Ind AS 108) "Operating Segments", constitutes a single operating segment. <BR> <BR> 6. The Company has allotted 105,432 shares (quarter ended March 31, 2025 : 464,800 shares) for the quarter and 472,514 shares (year ended March 31, 2025 :648,002 shares) for the year ended March 31, 2026 to eligible employees on exercise of Employee Stock options, in accordance with the terms and conditions of the IKS Employees Stock Options Plan 2022 named 'IKS Health - ESOP Policy 2022' as approved by the shareholders of the Company on April 22, 2022. Further, during the quarter and year ended March 31, 2026, the Company has granted 13,76,000 and 26,90,500 stock options respectively to eligible employees, as approved by the Nomination and Remuneration Committee. <BR> <BR> 7. Earnings per share for the interim periods are not annualised. <BR> <BR> 8. The consolidated financial results of the Group include the results of its subsidiary companies viz: Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited, Aquity Canada ULC and IKS Next Horizon, Inc. From the quarter ended September 30, 2025 the consolidated financial results also includes share of profit/(loss) from IKS WWMG MSO LLC, being an associate company. <BR> <BR> 9. On November 21, 2025, the Government of India notified the four consolidated Labour Codes, replacing multiple existing labour laws. Based on the draft rules and available guidance, the Company has assessed the impact of the revised wage definition on its employee benefit obligations in accordance with Ind AS 19. This assessment has resulted in a one-time estimated increase in employee benefit provisions, which is not material and has been recognised under Employee Benefits Expense in the current period. The Company will continue to monitor the finalisation of the relevant Central and State Rules and will account for any additional impacts in the period in which such Rules or clarifications are notified. <BR> <BR> 10. On April 23, 2026, Inventurus Knowledge Solutions, Inc., a wholly-owned subsidiary of the Company incorporated in the United States, entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG), a US-based provider of healthcare technology solutions for rural and community hospitals for an enterprise value of upto US$565 million. The acquisition is subject to customary conditions as specified in the agreement.2025-04-012026-03-31AuditedConsolidated319378800001719400003210982000000139100001627284000070248000012415000004737720000229684500009141370000091413700002003690000-170080000183361000007307760000000-9222000072155400001633040000884858000017071000012783166000043.1242.260043.1242.26Other Expenses1376740000Other Expenses473772000054068000001325842000056236500006133000015678500001931450000235930000291744000066526700001892510000865490000288947500005800002201020000564482000038871600001380000082880000012563180000687630000532670000137840600004267881000017071000027831660000280023700002800237000027499000007891400003539040000333980000110290000049759200003656770000301300001456920000148705000013223000006466120000203570000064409000055461000097005200001467644000042678810000Other Financial Assets2917440000Other non-current assets865490000Other Financial Assets828800000Other current assets513050000Contract assets19620000Other non- current financial Liabilities789140000Other current financial liabilities1322300000Other current liabilities20357000007007400000-134808000000-397640000-2025970000-2657600000200700000081686000010588000012415000000206470000000-31792000001546800004696700001121800000001514500000-5046000008636770000000190090000006735870000000145550000000001160000031516000000-2912500000000000000183920000000053160000081030000-2100040000001600200000000043852900007848300000343140000047186000000-4117990000517840000-12493000039291000014615500001854460000Remeasurement of post employment benefit obligations3950000Changes in the fair value of equity investments at FVOCI03950000Remeasurement of post employment benefit obligations-31550000Changes in the fair value of equity investments at FVOCI931520000899970000-28890000206530000Gains/ (losses) on cash flow hedges (net)-519280000Exchange differences on translation of financial statements of foreign operations880930000361650000Gains/ (losses) on cash flow hedges (net)-856300000Exchange differences on translation of financial statements of foreign operations1617530000761230000-107800000-1783700005022900001633040000AuditedtruePrice Waterhouse Chartered Accountants LLPtrue2026-11-30